Department of Medicinal Chemistry and Molecular Pharmacology Personnel - David A. Colby
Specialization: Medicinal Chemistry, Drug Discovery and Synthesis EducationPharm.D. - 2001 - University of IowaPh.D. - 2006 - University of California, Irvine Postdoc - 2006-2008 - The Scripps Research Institute (Dale L. Boger) Research: Medicinal Chemistry, Drug Discovery and SynthesisThe emergence of drug-resistant diseases has contributed to a growing need to develop new and innovative treatments for patients afflicted with these disease states. Our research interests are directed toward key therapeutic areas, such as cancer, which is one of the most prominent and deadly diseases when drug-resistance is present. Natural products have traditionally provided a rich source of drugs for many diseases, including cancer. In our laboratory, we seek to use natural products as potential leads for drug discovery in drug-resistant cancer. In order to accomplish these objectives, we will blend the science of medicinal chemistry and synthetic organic chemistry through the use of natural products chemistry, natural product synthesis, and the design of structurally-related analogues for structure-activity investigations. Specifically, we aim to selectively modify the complex structure of natural products and simultaneously understand the effects on biological activity. Natural products, such as parthenolide, santonin, and sclareolide, will be some of the targets that we will investigate to create new leads for drug-resistant cancers.
Representative PublicationsHan, C.; Salyer, A. E.; Kim, E. H.; Jiang, X.; Jarrard, R. E.; Powers, M. S.; Kirchhoff, A. M.; Salvador, T. K.; Chester, J. A.; Hockerman, G. H.; Colby, D. A. Evaluation of Difluoromethyl Ketones as Agonists of the gamma-Aminobutyric Acid Type B (GABA-B) Receptor. J. Med. Chem. 2013, 56, 2456–2465. DOI: 10.1021/jm301805e Riofski, M. V.; Hart, A. D.; Colby, D. A. Amidinate Salt of Hexafluoroacetone Hydrate for the Preparation of Fluorinated Compounds by the Release of Trifluoroacetate. Org. Lett. 2013, 15, 208–211. DOI: 10.1021/ol303291x Woods, J. R.; Mo, H.; Bieberich, A. A.; Alavanja, T.; Colby, D. A. Amino-derivatives of the Sesquiterpene Lactone Class of Natural Products as Prodrugs. MedChemComm 2013, 4, 27–33. [New Talent themed issue] DOI: 10.1039/c2md20172k Han, C.; Kim, E. H.; Colby, D. A. Cleaving Carbon-Carbon Bonds by the Release of Trifluoroacetate to Remodel Molecules and Assemble Fluorinate Structures. Synlett 2012, 23, 1559–1563. DOI: 10.1055/s-0031-1291156 Woods, J. R.; Mo, H.; Bieberich, A. A.; Alavanja, T.; Colby, D. A. Fluorinated Amino-Derivatives of the Sesquiterpene Lactone, Parthenolide, as 19F NMR Probes in Deuterium-Free Environments. J. Med. Chem. 2011, 54, 7934–7941. DOI: 10.1021/jm201114t John, J. P.; Colby, D. A. Synthesis of α-Halo-α,α-difluoromethyl Ketones by a Trifluoroacetate Release/Halogenation Protocol. J. Org. Chem. 2011, 76, 9163-9168. DOI: 10.1021/jo2017179 Riofski, M. V.; John, J. P.; Zheng, M. M.; Kirshner, J.; Colby, D. A. Exploiting the Facile Release of Trifluoroacetate for the α-Methylenation of the Sterically Hindered Carbonyl Groups on (+)-Sclareolide and (-)-Eburnamonine. J. Org. Chem. 2011, 76, 3676-3683. DOI: 10.1021/jo102114f Han, C.; Kim, E. H.; Colby, D. A. Cleavage of Carbon−Carbon Bonds through the Mild Release of Trifluoroacetate: Generation of α,α-Difluoroenolates for Aldol Reactions. J. Am. Chem. Soc. 2011, 133, 5802-5805. DOI: 10.1021/ja202213f Gunn, E. J.; Williams, J. T.; Huynh, D. T.; Iannotti, M. J.; Han, C.; Barrios, F. J.; Kendall, S.; Glackin, C. A.; Colby, D. A.; Kirshner, J. The Natural Products, Parthenolide and Andrographolide, Exhibit Anti-Cancer Stem Cell Activity in Multiple Myeloma. Leuk. Lymphoma 2011, 52, 1085-1097 . DOI: 10.3109/10428194.2011.555891 Barrios, F. J.; Zhang, X.; Colby, D. A. Dialkylaluminum N,O-Dimethylhydroxylamine Complex as a Reagent to Mask Reactive Carbonyl Groups in situ from Nucleophiles. Org. Lett. 2010, 12, 5588-5591. DOI: 10.1021/ol102495v This record was last updated on Apr 2, 2013 at 9:11 AM |



